Aortic aneurysm is a chronic disease characterized by localized expansion of the aorta,
including the ascending aorta, arch, descending aorta, and abdominal aorta. Although aortic …

Cardiovascular diseases lead the mortality and morbidity disease metrics worldwide. A
multitude of chemical base modifications in ribonucleic acids (RNAs) have been linked with …

The gene expression profile of abdominal aortic aneurysm (AAA) neck is not fully
understood. The etiology of AAA is considered to be related to atherosclerosis and the …

Background Aberrant expression of N6-methyladenosine (m6A) RNA modification
regulators plays a critical role in a variety of human diseases. However, their implication in …

Abdominal aortic aneurysm (AAA) is a chronic inflammatory degenerative aortic disease,
which particularly affects older people. Nucleotide-binding oligomerization domain-like …

Background. Dapagliflozin, a sodium glucose transporter protein‐2 (SGLT‐2) inhibitor,
reduces the risk for cardiovascular diseases. However, the influence of dapagliflozin on …

Importance The association of tyrosine kinase inhibitors targeting vascular endothelial
growth factor receptors (VEGFR-TKIs) with aneurysm and artery dissection (AAD) has been …

Heading aims Abdominal aortic aneurysm (AAA) is featured by the growth impediment and
apoptosis surge of VSMCs (vascular smooth muscle cells). MicroRNAs (miRNAs) are …

Background C-reactive protein (CRP) levels are elevated in patients with abdominal aortic
aneurysms (AAA). However, it has not been investigated whether CRP contributes to AAA …

Abdominal aortic aneurysms (AAAs) are typically asymptomatic, and there is a high mortality
rate associated with aneurysm rupture. AAA pathogenesis involves extracellular matrix …